Novartis to file Lucentis for rare sight condition in premature babies

24th September 2018 Uncategorised 0

Novartis has revealed its intent to file anti-VEGF therapy Lucentis for retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness.

More: Novartis to file Lucentis for rare sight condition in premature babies
Source: News